期刊文献+

肠道蛋白酶在失血性休克大鼠炎症反应中的作用 被引量:2

Effect of prolease in the lumen of rat intestine on inflammatory reaction during hemorrhagic shock
下载PDF
导出
摘要 目的通过肠道内灌注蛋白酶抑制剂乌司他丁(UTI),探讨肠道蛋白酶在失血性休克大鼠炎症反应中的作用。方法 28只Wistar大鼠(雌雄不限)随机分为4组:未灌注肠道组(A组)、盐水灌注肠道组(B组)、UTI灌注肠道组(C组)、静脉UTI组(D组)。记录各组大鼠平均动脉压和生存时间的变化,通过流式细胞术检测人粒细胞表面CD11b表达的变化,从而比较不同处理对大鼠血浆活性的影响。采用手工计数法计量不同时间点外周血白细胞数目,最后制作肠道组织病理切片,比较不同组别大鼠肠道黏膜的损害程度。结果 (1)平均动脉压:休克后,C组和D组大鼠血压下降较其他两组缓慢(P<0.05)。(2)生存时间:C组大鼠生存时间明显长于其余3组(P<0.05)。(3)血浆活性:休克后各组大鼠血浆活性均呈增高趋势,但C组活性与其他3组比较明显降低(P<0.05)。(4)外周血白细胞:休克后各组大鼠外周血白细胞总数呈下降趋势,但C组数目与其他3组比较明显升高(P<0.05)。(5)比较空肠黏膜组织病理变化发现,A组黏膜损害程度最深,B、D组次之,C组最轻。结论肠道内灌注蛋白酶抑制剂UTI可以延缓大鼠休克后血压下降过程,减弱血浆活性及炎症反应水平,最终延长生存时间,说明肠道蛋白酶在失血性休克大鼠炎症反应的发生发展中起重要作用。 Objective To investigate the effect of intraluminal administration of ulinastatin (a prolease inhibitor) in the intestine on intestinal inflammation in rats with hemorrhagic shock. Methods Twenty-eight Wistar rats were randomized into control group (A), intestinal saline perfusion group (B), ulinastatin intestinal perfusion group (C), and intravenous ulinastatin injection group (D) (n=7). The mean arterial blood pressure (MAP) and survival time of the rats were recorded. The changes in human polymorphonuclear cell (PMN) CD11b expression were detected by flow cytometry. The leukocyte count was recorded at different time points after the treatment, and the pathology of the intestinal mucosa was observed comparatively. Results Groups C and D showed significantly slower reduction of the MAP than groups A and B after hemorrhagic shock (P〈0.05). The survival time of the rats was the longest in group C (P〈0.05). CD11b expression increased gradually during hemorrhagic shock in all the groups, but the expression level was the lowest in group C (P〈0.05). Hemorrhagic shock caused a reduction in leukocyte counts, which remained the highest in group C (P〈0.05). Group C also showed the least intestinal pathology among the 4 groups. Conclusion Intestinal perfusion of ulinastatin can lower the reduction rate of MAP, attenuate plasma activation and intestinal inflammation, and prolong the survival of rats with hemorrhagic shock. These results indicate an important role of prolease in intestinal inflammation during hemorrhagic shock
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第6期1086-1089,共4页 Journal of Southern Medical University
基金 天普研究基金(01201028)
关键词 肠道灌注 蛋白酶抑制剂 乌司他丁 失血性休克 血浆活性因子 intestinal perfusion pancreatic proteases inhibition ulinastatin hemorrhagic shock plasma activity
  • 相关文献

参考文献10

  • 1Deitch EA. Multiple organ failure: pathophysiology and potential future therapy[J]. Ann Surg, 1992, 216(2): 117-34.
  • 2Schmid-Schonbein GW. 2008 landis award lecture inflammation and the autodigestion hypothesis[J]. Microcirculation, 2009, 16(4): 289-306.
  • 3Schmid-Schonbein GW. Biomechanical aspects of the auto- diges- tion theory[J]. Mol Cell Biomeeh, 2008, 5(2): 83-95.
  • 4Mitsuoka H, Kistler EB, Schmid-Schonbein GW. Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock[J]. Shock, 2002, 17(3): 205-9.
  • 5黄晓旭,全竹富,朱文强,李秋荣,黎介寿.大鼠肠缺血-再灌注损伤后细菌易位发生部位的实验研究[J].肠外与肠内营养,2010,17(4):239-242. 被引量:3
  • 6Troeger H, Richter JF, Beutin L, et al. Escherichia coli alpha- haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation [J]. Cell Microbiol, 2007, 9 (10): 2530-40.
  • 7蒋龙元,杨炼红,钟娃,何志捷,常建星,余涛,王彤,黄子通.乌司他丁对失血性休克大鼠的保护作用及其机制的研究[J].中国病理生理杂志,2005,21(9):1701-1704. 被引量:12
  • 8Ishimaru K, Mitsuoka H, Unno N, et al. Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanehnie arterial occlusion and reperfusion[J]. Shock, 2004, 22(5): 467-71.
  • 9Mitsuoka H, Kistler EB, Sehmid-Sch6nbein GW. Generation of in vivo activating factors in the isehemie intestine by pancreatic enzymes[J]. Proc Natl Acad Sei USA, 2000, 97(4): 1772-7.
  • 10Kistler EB, Hugli TE, Schmid-Schsnbein GW. The Pancreas as a source of cardiovascular cell activating factors[J]. Microcirculation, 2000, 7: 183-92.

二级参考文献7

  • 1Jian-Xing Chang,Shuang Chen,Li-Ping Ma,Long-Yuan Jiang,Jian-Wen Chen,Rui-Ming Chang,Li-Qiang Wen,Wei Wu,Zhi-Peng Jiang,Zi-Tong Huang.Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock[J].World Journal of Gastroenterology,2005,11(35):5485-5491. 被引量:45
  • 2Chaudry IH. Rat and mouse models of hypovolemic-traumatic shock[A]. In: Schlag G, Redl H. eds. Pathophysiology of shock, sepsis and organ failure[M]. Berlin: Springer- Verlag, 1993. 371-379.
  • 3Nakajima K, Goto Y. Differentiation of the anti- shock effect of ulinastatin from steroid hormone,by the continuous observation of microcirculation dynamics[J]. Circ Shock, 1992, 36(4): 284-289.
  • 4Takada K, Komori M, Notoya A, et al. Effect of ulinastatin on microcirculation during excessive hemorrhage using fluid therapy[J]. In Vivo, 2003, 17(2): 129-135.
  • 5Tamion F, Richard V, Bonmarchand G, et al. Reduced synthesis of inflammatory cytokines by a free radical scavenger after hemorrhagic shock in rats[J]. Crit Care Med, 2000, 28(7): 2522-2527.
  • 6马炳强,赵允召,赵坤,李秋荣,黎介寿.脓毒症时肠道细菌易位发生部位的研究[J].肠外与肠内营养,2010,17(3):156-159. 被引量:11
  • 7曾文红,白国强.乌司他丁研究进展[J].中华肝胆外科杂志,2001,7(1):52-54. 被引量:143

共引文献13

同被引文献21

  • 1王拥军,何士大.抗氧化中药的研究现状[J].中国中西医结合杂志,1996,16(5):312-314. 被引量:98
  • 2Suhartic C, VanGorp EC, Setiati TE, et al. The role of eytokines in activa- tion of coagulation and fibrinolysis in danger shock syndrome. Shock, 2002,87:42-46.
  • 3Peden M, Scurfield R, Sleet D, et al. World report on road traffic injury prevention. Geneva: WH0,2004:4533-4539.
  • 4Fu WJ,Teng QS,Li TS,et al. Fluid resuscitation in traumatic shock. Chin Crit Care Med,2003,15:759-741.
  • 5Gonser S, Crompton NE, Weber PJ, et al. TP5 triggers signal transduction involving mitogen activated protein kinases in monotyters. J Recept Signal Transduct Res, 1999,19 : 155-156.
  • 6Zhao XL, Sun X, Gao F, et al. Effects of ulinastatinand docataxel on breast tumor growth and expression of IL-6, IL-8 and TNF-a. J Experim Clin Cancer Res ,2011,30:22-25.
  • 7彭光宇主编.局部解剖学.第5版.北京:人民卫生出版社,2001.85-86.
  • 8Secchi A, Ortanderl JM, Schmidt W, et al. Effect of endotoxe mia on hepat- ic portal and sinusoidal blood flow in rats. J Surg Res,2000,89:26-30.
  • 9Moore FD,Warner KG,Assousa S, et al. The effects of complement acti- vation during cardiopulmonary bypass. Attenuation by hypothermia, hepa- tin and hemodilution. Ann Surg,2008 ,208 :95-102.
  • 10Fry DE. Sepsis syndrome. Am Surg,2000,66 : 126-132.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部